Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
May 25,2016
Sunscreen Gene May Guard Against Skin Cancer
Scientists at the University of Southern California (USC) say they've identified a so-called "sunscreen” gene that may help protect against skin cancer.  Melanoma—the deadliest form of skin cancer—has seen rates double over the last three decades, according to the CDC, causing scientists to be even more vigilant in their search to understand the underlying molecular mechanismsRead more
More
Sunscreen Gene May Guard Against Skin Cancer
May 24,2016
Appetite of Biomimicry Stem Cells for Nano Labels
If they are to be evaluated properly, stem cells that are deployed clinically need to be labeled. Even better, stem cells need to internalize tracking labels that can be picked up by means of magnetic resonance imaging (MRI). Yet stem cells such as mesenchymal stem cells (MSCs) seem to object to force-feeding, at least inRead more
More
May 24,2016
Killing MRSA with an Antarctic Sponge
    The exponential rise of antimicrobial resistance has sent researchers scrambling to identify novel compounds that can circumvent the microbial resistance mechanisms. This critical undertaking has caused many scientists to think outside the box and travel to extreme locations for new sources of antimicrobial compounds.     Scientists have isolated an extract from a sponge found in Antarctica,Read more
More
May 23,2016
Researchers Develop Non Toxic Approach for Treating Cancers
A team of researchers at Sylvester Comprehensive Cancer Center at the University of Miami, Miller School of Medicine recently discovered a novel, non-toxic approach to treating a wide variety of cancers. The treatment approach is based on a combination therapy of the sugar 2-Deoxy-D-glucose (2-DG) and fenofibrate, a well-studied cholesterol medication. The study was publishedRead more
More
May 23,2016
Comet Clues Lead to RNA World Revelations
    "The cosmos is within us,” said Carl Sagan. "We are made of star stuff.” Memorable words, but they don't explain how "star stuff”—pretty much all the chemical elements—could have come together in various ways to form life's chemical building blocks—proteins and nucleic acids. No doubt Sagan was aware that the story of chemical evolution stillRead more
More
May 20,2016
Study Advances Understanding of Colon Cancer
    Inflammatory bowel disease (IBD), of which Crohn's disease and ulcerative colitis are the main types, is on the increase in the United States, affecting more than 1.6 million people and explaining perhaps the increase in advertisements offering treatments and cures. Another intestinal disease is colon cancer, a leading cause of death, which is linked toRead more
More
Study Advances Understanding of Colon Cancer
May 20,2016
Blocking Know Cancer Driver Unexpectedly Reveals a New Tumor Promoting Pathway
    While investigating a potential therapeutic target for the ERK1 and 2 pathways, a widely expressed signaling molecule known to drive cancer growth in one third of patients with colorectal cancer, University of California San Diego School of Medicine researchers found that an alternative pathway immediately emerges when ERK1/2 is halted, thus allowing tumor cell proliferationRead more
More
Blocking Know Cancer Driver Unexpectedly Reveals a New Tumor Promoting Pathway
May 19,2016
Stem Cell Factor Boosts Cardiovascular Protection
    Oct4, a gene essential to embryonic development, remains functional in adults, offering cardiovascular protection through the stabilization of atherosclerotic plaques. Essentially, Oct4 helps prevent heart attacks and strokes.       The finding is a surprise. While there had been hints that Oct4 could serve some function later in life, convincing evidence was lacking. Now that Oct4Read more
More
Stem Cell Factor Boosts Cardiovascular Protection
May 19,2016
Anchors Provide Novel Way to Hijack Superbugs
Scientists at Monash University of Australia may have found a way to stop deadly bacteria from infecting patients. The discovery could lead to a whole new way of treating antibiotic-resistant "superbugs.” The researchers have uncovered what may be an Achilles heel on the bacteria cell membrane that could act as a potential novel drug target.Read more
More
Anchors Provide Novel Way to Hijack Superbugs
May 18,2016
Altering the Microbiome Improves Stress Resistance and Coping Responses
    Injections of the soil bacterium Mycobacterium vaccae promote stress resilience and improve coping behaviors in mice, according to a new study led by researchers at University of California San Diego School of Medicine and University of Colorado Boulder. The researchers also found that M. vaccae prevented stress-induced colitis, a typical symptom of inflammatory bowel disease, suggesting that immunizationRead more
More
Altering the Microbiome Improves Stress Resistance and Coping Responses
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->